DE69716602D1 - Substituierte 3,5-diphenyl-1,2,4-triazole und ihre verwenung als pharmazeutischemetallchelatoren - Google Patents

Substituierte 3,5-diphenyl-1,2,4-triazole und ihre verwenung als pharmazeutischemetallchelatoren

Info

Publication number
DE69716602D1
DE69716602D1 DE69716602T DE69716602T DE69716602D1 DE 69716602 D1 DE69716602 D1 DE 69716602D1 DE 69716602 T DE69716602 T DE 69716602T DE 69716602 T DE69716602 T DE 69716602T DE 69716602 D1 DE69716602 D1 DE 69716602D1
Authority
DE
Germany
Prior art keywords
triazoles
diphenyl
substituted
metal chelators
pharmaceutical metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69716602T
Other languages
English (en)
Other versions
DE69716602T2 (de
DE122007000020I1 (de
Inventor
Rene Lattmann
Pierre Acklin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4214048&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69716602(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Priority to DE122007000020C priority Critical patent/DE122007000020I2/de
Application granted granted Critical
Publication of DE69716602D1 publication Critical patent/DE69716602D1/de
Publication of DE69716602T2 publication Critical patent/DE69716602T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69716602T 1996-06-25 1997-06-24 Substituierte 3,5-diphenyl-1,2,4-triazole und ihre verwenung als pharmazeutischemetallchelatoren Expired - Lifetime DE69716602T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE122007000020C DE122007000020I2 (de) 1996-06-25 1997-06-24 Substituierte 3,5-diphenyl-1,2,4-triazole und ihre verwendung als pharmazeutische metallchelatoren

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH159396 1996-06-25
PCT/EP1997/003315 WO1997049395A1 (en) 1996-06-25 1997-06-24 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators

Publications (2)

Publication Number Publication Date
DE69716602D1 true DE69716602D1 (de) 2002-11-28
DE69716602T2 DE69716602T2 (de) 2003-06-26

Family

ID=4214048

Family Applications (3)

Application Number Title Priority Date Filing Date
DE1997616602 Pending DE122007000020I1 (de) 1996-06-25 1997-06-24 Substituierte 3,5-diphenyl-1,2,4-Triazole und ihreVerwenung als Pharmazeutischemetallchelatoren
DE122007000020C Active DE122007000020I2 (de) 1996-06-25 1997-06-24 Substituierte 3,5-diphenyl-1,2,4-triazole und ihre verwendung als pharmazeutische metallchelatoren
DE69716602T Expired - Lifetime DE69716602T2 (de) 1996-06-25 1997-06-24 Substituierte 3,5-diphenyl-1,2,4-triazole und ihre verwenung als pharmazeutischemetallchelatoren

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE1997616602 Pending DE122007000020I1 (de) 1996-06-25 1997-06-24 Substituierte 3,5-diphenyl-1,2,4-Triazole und ihreVerwenung als Pharmazeutischemetallchelatoren
DE122007000020C Active DE122007000020I2 (de) 1996-06-25 1997-06-24 Substituierte 3,5-diphenyl-1,2,4-triazole und ihre verwendung als pharmazeutische metallchelatoren

Country Status (37)

Country Link
US (3) US6465504B1 (de)
EP (1) EP0914118B1 (de)
JP (1) JP3541042B2 (de)
KR (1) KR100616378B1 (de)
CN (1) CN1146415C (de)
AP (1) AP1127A (de)
AR (1) AR007479A1 (de)
AT (1) ATE226435T1 (de)
AU (1) AU718037B2 (de)
BG (1) BG64248B1 (de)
BR (1) BR9709973A (de)
CA (1) CA2255951C (de)
CY (2) CY2429B1 (de)
CZ (1) CZ291470B6 (de)
DE (3) DE122007000020I1 (de)
DK (1) DK0914118T3 (de)
ES (1) ES2187785T3 (de)
FR (1) FR06C0049I2 (de)
GE (1) GEP20084355B (de)
HK (1) HK1020530A1 (de)
HU (1) HU226232B1 (de)
IL (1) IL127212A0 (de)
LT (1) LTC0914118I2 (de)
LU (1) LU91291I2 (de)
MY (1) MY129541A (de)
NL (1) NL300248I2 (de)
NO (3) NO317180B1 (de)
NZ (1) NZ333308A (de)
OA (1) OA10946A (de)
PL (1) PL194758B1 (de)
PT (1) PT914118E (de)
RU (1) RU2208010C2 (de)
SI (1) SI0914118T1 (de)
SK (1) SK284319B6 (de)
TR (1) TR199802693T2 (de)
TW (1) TW533205B (de)
WO (1) WO1997049395A1 (de)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6677487B2 (en) 2001-08-30 2004-01-13 Pharmacia Corporation α-haloenamine reagents
GB0126618D0 (en) * 2001-11-06 2002-01-02 Novartis Ag Organic compounds
ES2192494B1 (es) * 2002-03-27 2005-02-16 Consejo Superior De Investigaciones Cientificas Derivados de 1,2,4-triazol con propiedades cannabinoides.
US8829198B2 (en) * 2007-10-31 2014-09-09 Proteotech Inc Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
GB0223978D0 (en) * 2002-10-15 2002-11-20 Novartis Ag Organic compound
US20050008699A1 (en) * 2003-07-11 2005-01-13 Fred Wehling Effervescent glucosamine composition
BRPI0417759A (pt) * 2003-12-19 2007-04-10 Novartis Ag combinação de (a) n-{5-[4-(metil-piperazino-metil)-benzoilamido]-2-metilf enil}-4-(3-piridil)-2-pirimidina-amina e (b) pelo menos um inibidor de hipusinação e o seu uso
GB0408078D0 (en) * 2004-04-08 2004-05-12 Novartis Ag Organic compounds
US9737511B2 (en) * 2004-05-24 2017-08-22 Geoffrey C. GURTNER Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux
EP1755579A4 (de) * 2004-05-24 2009-06-10 Univ New York Verfahren zur behandlung oder prävention von pathologischen wirkungen einer akuten zunahme von hyperglykämie und/oder einer akuten zunahme von freiem fettsäurefluss
DK1843771T3 (da) * 2005-01-28 2012-01-16 Novartis Ag Anvendelse af pyrimidylaminobenzamider til behandling af sygdomme, der responderer på modulation af Tie-2-kinase-aktiviteten
KR20070101314A (ko) * 2005-02-10 2007-10-16 노파르티스 아게 약물 처리과정을 개선하기 위한 방법
MX2007015085A (es) * 2005-05-31 2008-01-17 Novartis Ag Tratamiento de enfermedades del higado en donde el hierro juega un papel importante en patogenesis.
AU2006303514B2 (en) * 2005-10-19 2010-06-24 Novartis Ag Dispersible tablets comprising deferasirox
PL1945272T3 (pl) 2005-11-01 2014-03-31 Novartis Ag Sposób prowadzenia scyntygraffi
BRPI0711385A2 (pt) * 2006-05-09 2011-11-08 Novartis Ag combinação compreendendo um quelante de ferro e um agente anti-neoplástico e seu uso
MX2008014837A (es) 2006-05-23 2008-12-01 Novartis Ag Metodo para el tratamiento de hemocromatosis hereditaria.
CL2007002026A1 (es) 2006-07-13 2008-06-06 Los Angeles Biomed Res Inst Composicion que comprende al menos un compuesto quelante de hierro y al menos un agente antifungico; y metodo para el tratamiento o prevencion de una condicion fungica.
AU2007280639A1 (en) * 2006-08-04 2008-02-07 Novartis Ag Treatment of endocrine dysfunction using iron chelators
BRPI0720793A2 (pt) 2006-11-29 2014-03-11 Novartis Ag SAIS E FORMAS CRISTALINAS DE ÁCIDO 4-[3,5-BIS(2-HIDRÓXI FENIL)-[1,2,4]tRIAZOL-1-IL]BENZOICO
EP1927591A1 (de) * 2006-11-29 2008-06-04 Novartis AG Polymorphe Formen des Deferasirox (ICL670)
EP2108013A2 (de) * 2007-01-29 2009-10-14 Teva Gyógyszergyár Zártköruen Muködo Részvénytársaság Kristalline formen von deferasirox
AU2008250041A1 (en) * 2007-05-14 2008-11-20 Novartis Ag Use of iron chelator for the treatment of myocardial infarction
EP1994930A1 (de) * 2007-05-22 2008-11-26 Novartis AG Triazol-Verbindungen zur Behandlung der Biofilm Bildung
WO2009016359A1 (en) * 2007-07-27 2009-02-05 Pliva Hrvatska D.O.O. New forms of deferasirox
US20090082412A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched deferasirox
US20090142395A1 (en) 2007-11-19 2009-06-04 Uri Zadok Deferasirox pharmaceutical compositions
CZ301873B6 (cs) * 2008-01-30 2010-07-14 Farmak, A. S. Zpusob prípravy kyseliny 4-[3,5-bis(2-hydroxyfenyl)-[1,2,4]triazol-1-yl]benzoové
WO2009106824A2 (en) * 2008-02-25 2009-09-03 Cipla Limited Pharmaceutical formulations
WO2009111611A2 (en) 2008-03-05 2009-09-11 Proteotech Inc. Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
WO2009130604A2 (en) * 2008-04-21 2009-10-29 Actavis Group Ptc Ehf Solid state forms of deferasirox salts and process for the preparation thereof
US20110171138A1 (en) * 2008-06-02 2011-07-14 Actavis Group Ptc Ehf Substantially pure deferasirox and processes for the preparation thereof
TWI488624B (zh) 2008-09-22 2015-06-21 Nat University Corp Asahikawa Medical College 鐵螯合劑、其製造方法及鐵離子之定量、捕捉方法
US10098857B2 (en) 2008-10-10 2018-10-16 The Board Of Trustees Of The Leland Stanford Junior University Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds
WO2010092419A1 (en) 2009-02-12 2010-08-19 Assistance Publique - Hopitaux De Paris Combined treatment of multiple sclerosis
MX2011009735A (es) 2009-03-19 2011-10-19 Los Angeles Biomed Res Inst Composiciones de vacuna y metodos para el tratamiento de mucormicosis y otras enfermedades fungicas.
IT1398770B1 (it) * 2009-07-22 2013-03-18 Bellacchio Oligonucleotidi attivabili mediante l'appaiamento con sequenze di acidi nucleici e loro uso
WO2011021218A2 (en) * 2009-08-12 2011-02-24 Msn Laboratories Limited Process for the preparation of 4-[3,5-bis(2-hydroxyphenyl)-1h-1,2,4-triazol-1-yl]-benzoic acid and its amine salts
US8772503B2 (en) 2009-12-07 2014-07-08 Mapi Pharma Ltd. Processes for the preparation of deferasirox, and deferasirox polymorphs
EP2929877A1 (de) 2010-07-08 2015-10-14 ratiopharm GmbH Orale darreichungsform von deferasirox
EP2632907B1 (de) * 2010-08-25 2015-10-14 Davuluri, Ramamohan Rao Verfahren zur herstellung von 2-(2-hydroxyphenyl-)benz-[1,3-]oxazin-4-on und seine verwendung zur herstellung von deferasirox
PE20170468A1 (es) * 2010-10-01 2017-04-26 Cipla Ltd Composicion farmaceutica que comprende deferasirox
WO2012069946A1 (en) * 2010-11-24 2012-05-31 Alembic Pharmaceuticals Limited Process for the preparation of deferasirox
US9796605B2 (en) 2011-01-14 2017-10-24 Disease Adsorption System Technologies Co., Ltd. Polymeric iron chelating agent
US20140316534A1 (en) 2011-10-14 2014-10-23 Photocure Asa Stent
EP2766049A1 (de) 2011-10-14 2014-08-20 Photocure ASA Photodynamische diagnose von abweichungen des epithels der speiseröhre mit einem 5-ala ester
US8822464B2 (en) 2011-11-28 2014-09-02 Boehringer Ingelheim International Gmbh N-aryl-piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
US8741892B2 (en) 2011-12-05 2014-06-03 Boehringer Ingelheim International Gmbh Compounds
US8642774B2 (en) * 2011-12-08 2014-02-04 Boehringer Ingelheim International Gmbh Compounds
US8846948B2 (en) 2011-12-13 2014-09-30 Boehringer Ingelheim International Gmbh Compounds
US8796467B2 (en) 2011-12-13 2014-08-05 Boehringer Ingelheim International Gmbh Compounds
US8937176B2 (en) 2011-12-14 2015-01-20 Boehringer Ingelheim International Gmbh Compounds
US8883789B2 (en) 2011-12-14 2014-11-11 Boehringer Ingelheim International Gmbh Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
US8716277B2 (en) 2011-12-14 2014-05-06 Boehringer Ingelheim International Gmbh Substituted imidazole compounds useful as positive allosteric modulators of mGlu5 receptor activity
US8889677B2 (en) * 2012-01-17 2014-11-18 Boehringer Ingellheim International GmbH Substituted triazoles useful as mGlu5 receptor modulators
PL2964659T3 (pl) * 2013-03-06 2018-04-30 Biocon Limited Sposób wytwarzania deferazyroksu
SI2964202T1 (sl) * 2013-03-08 2019-02-28 Novartis Ag Peroralne formulacije deferasiroksa
ZA201403276B (en) * 2013-05-10 2015-07-29 Cipla Ltd Low dose pharmaceutical composition
DE102013217390A1 (de) 2013-09-02 2015-03-05 Henkel Ag & Co. Kgaa Wasch- und Reinigungsmittel mit verbesserter Leistung
CN103454370B (zh) * 2013-09-11 2014-12-24 中美华世通生物医药科技（武汉）有限公司 一种利用hplc测定原料药中苯肼类化合物残留的方法
JOP20200094A1 (ar) 2014-01-24 2017-06-16 Dana Farber Cancer Inst Inc جزيئات جسم مضاد لـ pd-1 واستخداماتها
JOP20200096A1 (ar) 2014-01-31 2017-06-16 Children’S Medical Center Corp جزيئات جسم مضاد لـ tim-3 واستخداماتها
TWI777174B (zh) 2014-03-14 2022-09-11 瑞士商諾華公司 針對lag-3之抗體分子及其用途
PT2946771T (pt) 2014-05-20 2019-06-27 Sanovel Ilac Sanayi Ve Ticaret As Formulação de comprimido dispersível em água compreendendo deferasirox
EP2987482A1 (de) 2014-08-22 2016-02-24 Santa Farma Ilaç Sanayi A.S. Lösliche und dispergierbare pharmazeutische Formulierung enthaltend Deferasirox
MA41044A (fr) 2014-10-08 2017-08-15 Novartis Ag Compositions et procédés d'utilisation pour une réponse immunitaire accrue et traitement contre le cancer
CN114920840A (zh) 2014-10-14 2022-08-19 诺华股份有限公司 针对pd-l1的抗体分子及其用途
US20170340733A1 (en) 2014-12-19 2017-11-30 Novartis Ag Combination therapies
KR20160088965A (ko) 2015-01-16 2016-07-27 대원제약주식회사 데페라시록스를 함유하는 현탁제
US10449211B2 (en) 2015-03-10 2019-10-22 Aduro Biotech, Inc. Compositions and methods for activating “stimulator of interferon gene”—dependent signalling
CN104817538A (zh) * 2015-03-13 2015-08-05 东南大学 去铁斯诺-他克林金属离子鳌合剂及其药物用途
WO2016167729A1 (en) 2015-04-16 2016-10-20 Öğün Yusuf Toktamiş Dispersible tablets comprising deferasirox
EP3095443A1 (de) 2015-05-21 2016-11-23 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. Pharmazeutische zusammensetzung mit deferasirox
WO2016203488A1 (en) * 2015-06-16 2016-12-22 Havaldar Freddy H Preparation of novel deferasirox analogues for antimalarial activity
EP3964528A1 (de) 2015-07-29 2022-03-09 Novartis AG Kombinationstherapien mit antikörpermolekülen gegen lag-3
EP3878465A1 (de) 2015-07-29 2021-09-15 Novartis AG Kombinationstherapien mit antikörpermolekülen gegen tim-3
KR101695970B1 (ko) * 2015-07-31 2017-01-13 건일제약 주식회사 데페라시록스 함유 산제 및 그 제조방법
CN106554770B (zh) * 2015-09-29 2018-10-19 杭州杜易科技有限公司 一种三唑衍生物金属离子荧光探针及其制备方法和应用
CN108290878B (zh) 2015-10-23 2022-04-26 威佛（国际）股份公司 新的膜铁转运蛋白抑制剂
AU2016369537B2 (en) 2015-12-17 2024-03-14 Novartis Ag Antibody molecules to PD-1 and uses thereof
EP3429562A1 (de) 2016-03-17 2019-01-23 Lupin Limited Zusammensetzungen aus deferasirox
WO2018009466A1 (en) 2016-07-05 2018-01-11 Aduro Biotech, Inc. Locked nucleic acid cyclic dinucleotide compounds and uses thereof
EP3518904A1 (de) 2016-09-30 2019-08-07 Synthon B.V. Pharmazeutische zusammensetzung mit deferasirox
JOP20180036A1 (ar) 2017-04-18 2019-01-30 Vifor Int Ag أملاح لمثبطات فروبورتين جديدة
UY37695A (es) 2017-04-28 2018-11-30 Novartis Ag Compuesto dinucleótido cíclico bis 2’-5’-rr-(3’f-a)(3’f-a) y usos del mismo
CZ2017255A3 (cs) 2017-05-04 2018-11-14 Zentiva, K.S. Filmem potažené tablety Deferasiroxu
WO2018208242A1 (en) 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability
EP3642240A1 (de) 2017-06-22 2020-04-29 Novartis AG Antikörpermoleküle gegen cd73 und verwendungen davon
WO2019055490A1 (en) 2017-09-14 2019-03-21 The Board Of Trustees Of The Leland Stanford Junior University PACKAGING OF IRRADIED FABRIC FOR FAT GREETING RETENTION
EP3489692A1 (de) 2017-11-28 2019-05-29 Siemens Healthcare Diagnostics Products GmbH Prothrombinzeit-reagenz enthaltend einen eisenchelator
TR201722910A2 (tr) 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari
KR20190110771A (ko) 2018-03-21 2019-10-01 주식회사 한국팜비오 데페라시록스를 함유하는 소형 분산성 정제
CN108727287B (zh) * 2018-05-10 2020-10-27 东南大学 1,2,4-三唑类化合物及其盐和应用
AR126019A1 (es) 2018-05-30 2023-09-06 Novartis Ag Anticuerpos frente a entpd2, terapias de combinación y métodos de uso de los anticuerpos y las terapias de combinación
GR1009592B (el) * 2018-07-03 2019-09-11 Φαρματεν Α.Β.Ε.Ε. Φαρμακευτικο σκευασμα που περιλαμβανει εναν χηλικο παραγοντα συμπλεκτικο του σιδηρου και μεθοδος για την παρασκευη αυτου
KR20200113116A (ko) 2019-03-22 2020-10-06 주식회사 한국팜비오 데페라시록스를 포함하는 필름코팅정제
TW202102478A (zh) 2019-04-01 2021-01-16 瑞士商威佛（國際）股份有限公司 新穎的鐵螯合物
EP4031578A1 (de) 2019-09-18 2022-07-27 Novartis AG Entpd2-antikörper, kombinationstherapien und verfahren zur verwendung der antikörper und kombinationstherapien
IT202000000922A1 (it) 2020-01-20 2021-07-20 Cage Chemicals S R L Complessi di ferro e relativi sali come agenti di contrasto per MRI
WO2022186809A1 (en) 2021-03-05 2022-09-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi The film coated tablet comprising deferasirox
CN114276305B (zh) * 2021-12-28 2023-11-17 中山大学 一种三取代苯基-1,2,4-三氮唑衍生物及其制备和治疗神经元损伤的应用
CN114478410B (zh) * 2022-03-31 2022-11-29 中山大学 一种二取代苯基-1,2,4-三氮唑衍生物及其制备和应用
CN114591254B (zh) * 2022-03-31 2023-10-13 中山大学 一种3,5-二取代苯基-1,2,4-三氮唑衍生物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH388252A (de) 1963-01-24 1964-11-14 Geigy Ag J R Verfahren zum Schützen von Textilmaterial gegen Lichtschädigung
DE2628152C2 (de) 1976-06-23 1985-03-28 Bayer Ag, 5090 Leverkusen Fungizide und nematizide Mittel
US4528196A (en) * 1981-02-23 1985-07-09 The United States Of America As Represented By The Department Of Health And Human Services Chelating agents for the treatment of iron overload
GB8429307D0 (en) 1984-11-20 1984-12-27 Shell Int Research Heterocyclic herbicides
IL84331A0 (en) * 1987-11-02 1988-04-29 Yissum Res Dev Co Pyridoxyl hydrazone derivatives and pharmaceutical compositions containing the same
US5260322A (en) 1990-10-08 1993-11-09 Merck & Co., Inc. Angiotension II antagonists in the treatment of hyperuricemia
DE4320801A1 (de) * 1993-06-23 1995-01-05 Fahlberg List Pharma Gmbh 2-Hydroxyphenylsubstituierte 1,2,4-Triazole und 1,2,4-Oxadiazole, ihre Verwendung als pharmazeutische Wirkstoffe und sie enthaltende Arzneimittel

Also Published As

Publication number Publication date
NO2006017I1 (no) 2006-12-18
FR06C0049I2 (fr) 2007-04-27
NO2006017I2 (no) 2011-07-04
ES2187785T3 (es) 2003-06-16
LTC0914118I2 (lt) 2018-12-27
JP2000507601A (ja) 2000-06-20
BG64248B1 (bg) 2004-07-30
PL330119A1 (en) 1999-04-26
AP9801407A0 (en) 1998-12-31
US6465504B1 (en) 2002-10-15
DE69716602T2 (de) 2003-06-26
CY2007005I2 (el) 2018-12-12
CY2007005I1 (el) 2010-07-28
DK0914118T3 (da) 2003-02-24
NO986024L (no) 1998-12-21
BG103003A (en) 1999-09-30
US6723742B2 (en) 2004-04-20
KR100616378B1 (ko) 2006-08-28
CA2255951C (en) 2006-10-10
NL300248I1 (nl) 2007-02-01
KR20050098029A (ko) 2005-10-10
NZ333308A (en) 2000-05-26
RU2208010C2 (ru) 2003-07-10
CA2255951A1 (en) 1997-12-31
CN1146415C (zh) 2004-04-21
DE122007000020I2 (de) 2010-12-30
CZ291470B6 (cs) 2003-03-12
DE122007000020I1 (de) 2007-05-24
US20030069273A1 (en) 2003-04-10
HK1020530A1 (en) 2000-05-12
SK178598A3 (en) 1999-06-11
HUP9903111A2 (hu) 2000-01-28
NL300248I2 (nl) 2007-03-01
ATE226435T1 (de) 2002-11-15
PL194758B1 (pl) 2007-07-31
WO1997049395A1 (en) 1997-12-31
NO2018014I1 (no) 2018-04-17
EP0914118A1 (de) 1999-05-12
GEP20084355B (de) 2008-04-29
AU718037B2 (en) 2000-04-06
SI0914118T1 (en) 2003-04-30
HUP9903111A3 (en) 2000-06-28
US6596750B2 (en) 2003-07-22
BR9709973A (pt) 1999-08-10
AR007479A1 (es) 1999-10-27
NO986024D0 (no) 1998-12-21
NO2018014I2 (no) 2018-11-19
OA10946A (en) 2003-02-27
SK284319B6 (sk) 2005-01-03
IL127212A0 (en) 1999-09-22
PT914118E (pt) 2003-02-28
JP3541042B2 (ja) 2004-07-07
HU226232B1 (en) 2008-07-28
NO317180B1 (no) 2004-09-06
AP1127A (en) 2002-12-06
CN1223579A (zh) 1999-07-21
TR199802693T2 (xx) 1999-05-21
LTPA2007001I1 (lt) 2018-06-25
CZ427298A3 (cs) 1999-03-17
MY129541A (en) 2007-04-30
LU91291I2 (fr) 2007-01-29
LU91291I9 (de) 2018-12-27
TW533205B (en) 2003-05-21
US20030203954A1 (en) 2003-10-30
AU3262997A (en) 1998-01-14
CY2429B1 (en) 2004-11-12
FR06C0049I1 (de) 2007-03-09
EP0914118B1 (de) 2002-10-23

Similar Documents

Publication Publication Date Title
DE69716602T2 (de) Substituierte 3,5-diphenyl-1,2,4-triazole und ihre verwenung als pharmazeutischemetallchelatoren
DE69618959T2 (de) Pyrimidone und ihre verwendug als fungizide
DE69713284D1 (de) Triazol-Derivate als Arzneimittel
DE59710423D1 (de) Triazolyl-mercaptide und ihre verwendung als mikrobizide
DE69303864T2 (de) Neue 3,5-Diphenyl-substituierte 1,2,4-Triazole und ihre Verwendung als Insektizide und Akarizide
ATE246186T1 (de) Triazol enthaltende antifungale mittel
DE69613805D1 (de) Diiminoquinonderivate und ihre Verwendung als Elektronübertragungsmittel
DE69811018D1 (de) Triazol-Derivate und ihre Verwendung als antimykotische Mittel
DE59709790D1 (de) Mercapto-imidazolyl-derivate und ihre verwendung als mikrobizide
DE59711502D1 (de) Oximderivate und ihre verwendung als fungizide
DE59610382D1 (de) Halogenbenzimidazole und ihre verwendung als mikrobizide
DE69607578T2 (de) Diiminoquinonderivate und ihre Verwendung als Elektronübertragungsmittel
DE69718850T2 (de) Heterocyclische N-Acetonylbenzamide und ihre Verwendung als Fungizide
ITPN940023A0 (it) Mobile metallico per comunita'
FI973845A (fi) Imidatsoli-, triatsoli- ja tetratsolijohdannaisia
KR960021778U (ko) 금속제 부품 보관구
GB9620738D0 (en) Sordarin and derivatives thereof for use as crop antifungal agents